A Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives
Kidney Diseases · 2024 · 10 (3) · 224-236
DOI: 10.1159/000538106 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Kidney Diseases, online erschienen am 08.03.2024. Verfasst von Zhongyu Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: Ferroptosis, a newly recognized form of programmed cell death, is distinguished by its reliance on reactive oxygen species and iron-mediated lipid peroxidation, setting it apart from established types like apoptosis, cell necrosis, and autophagy. Recent studies suggest its role in exacerbating or mitigating diseases by influencing metabolic and signaling pathways in conditions such as tumors and ischemic organ damage. Evidence also links ferroptosis to various kidney diseases, prompting a review of its research status and potential breakthroughs in understanding and treating these conditions. Summary: In acute kidney disease (AKI), ferroptosis has been confirmed in animal kidneys after being induced by various factors such as renal ischemia-reperfusion and cisplatin, and glutathione peroxidase 4 (GPX4) is linked with AKI. Ferroptosis is associated with renal fibrosis in chronic kidney disease (CKD), TGF-β1 being crucial in this regard. In diabetic nephropathy (DN), high SLC7A11 and low nuclear receptor coactivator 4 (NCOA4) expressions are linked to disease progression. For polycystic kidney disease (PKD), ferroptosis promotes the disease by regulating ferroptosis in kidney tissue. Renal cell carcinoma (RCC) and lupus nephritis (LN) also have links to ferroptosis, with mtDNA and iron accumulation causing RCC and oxidative stress causing LN. Key Messages: Ferroptosis is a newly identified form of programmed cell death that is associated with various diseases. It targets metabolic and signaling pathways and has been linked to kidney diseases such as AKI, CKD, PKD, DN, LN, and clear cell RCC. Understanding its role in these diseases could lead to breakthroughs in their pathogenesis, etiology, and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Eye School of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Zitieren
APA
Han, Z., Luo, Y., Chen, H., Zhang, G., You, L., Zhang, M., Lin, Y., Yuan, L., & Zhou, S. (2024). A Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives. Kidney Diseases, 10(3), 224-236. https://doi.org/10.1159/000538106
Vancouver
Han Z, Luo Y, Chen H, Zhang G, You L, Zhang M, et al. A Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives. Kidney Diseases. 2024;10(3):224-236. doi:10.1159/000538106
BibTeX
@article{Han2024,
author = {Han, Zhongyu and Luo, Yuanke and Chen, Haoran and Zhang, Guochen and You, Luling and Zhang, Meiqi and Lin, Yumeng and Yuan, Lan and Zhou, Shiyi},
title = {A Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives},
journal = {Kidney Diseases},
year = {2024},
volume = {10},
number = {3},
pages = {224--236},
doi = {10.1159/000538106}
}
EUVIMED